Peninsula biotech InterVenn terminates South San Francisco lease amid flooded life sciences market

The company, which has raised close to $300 million, counts among its founders Carolyn Bertozzi, a Stanford University chemistry professor and 2022 winner of the Nobel Prize.
Source: Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news